Welcome to our dedicated page for Kadant SEC filings (Ticker: KAI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Kadant Inc. (NYSE: KAI) SEC filings page provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Kadant is incorporated in Delaware and lists its common stock on the New York Stock Exchange under the symbol KAI, as noted in its Form 8-K filings. Through these documents, investors can review how the company reports its financial results, describes material events, and manages its capital structure.
Regular current reports on Form 8-K furnish Kadant’s quarterly earnings press releases and investor presentation materials. In these filings, the company discusses revenue, net income, earnings per share, bookings, and cash flow, and presents non-GAAP measures such as organic revenue, adjusted net income, adjusted EPS, EBITDA, adjusted EBITDA, adjusted EBITDA margin, and free cash flow. The filings explain which items are excluded from these non-GAAP metrics and why management uses them to assess underlying performance.
Other 8-K filings document material corporate actions, such as the completion of the acquisition of Clyde Industries Holdings, Inc. and amendments to Kadant’s Amended and Restated Credit Agreement. For example, one filing describes an Eighth Amendment that increased revolving loan commitments, extended the maturity of the unsecured credit facility, adjusted multicurrency and letter of credit sublimits, and added an Australian subsidiary as an authorized borrower. These disclosures help readers understand Kadant’s financing arrangements and acquisition activity.
On Stock Titan, Kadant’s filings are updated as they are made available through the EDGAR system. AI-powered summaries highlight the key points in lengthy documents, helping users quickly identify items related to earnings, credit facilities, acquisitions, and other significant developments. Investors can also use this page to trace the history of Kadant’s reported non-GAAP measures, review the terms of its credit agreements, and follow the regulatory record surrounding its strategic transactions.
Kadant Inc. director Thomas C. Leonard reported receiving a grant of 513 Restricted Stock Units on March 11, 2026. Each RSU represents one share of Kadant common stock and will vest in equal installments on the last day of each fiscal 2026 quarter, as long as he continues to serve as a director.
Following this award, Leonard holds 4,513 shares of Kadant common stock directly, and 513 RSUs that are scheduled to convert into additional shares as they vest.
Painter Jonathan W reported acquisition or exercise transactions in this Form 4 filing.
KADANT INC director Jonathan W. Painter received a grant of 513 Restricted Stock Units (RSUs) on common stock. Each RSU represents one share of Kadant common stock and vests in equal installments on the last day of each fiscal 2026 quarter, as long as he continues serving as a director. After this award, he directly holds 513 RSUs and 8,748 common shares, plus 3 additional common shares held indirectly by his son.
O'Mara Rebecca Martinez reported acquisition or exercise transactions in this Form 4 filing.
Kadant Inc. director Rebecca Martinez O'Mara received a grant of 513 Restricted Stock Units. Each RSU represents the right to receive one share of Kadant common stock, vesting in equal installments on the last day of each Kadant fiscal quarter in 2026, as long as she continues serving as a director.
Following this grant, she directly holds 1,272 shares of Kadant common stock, in addition to the new RSU award. This filing reflects a routine, stock-based compensation grant rather than an open-market purchase or sale.
Russell Erin L reported acquisition or exercise transactions in this Form 4 filing.
Kadant Inc. director Erin L. Russell received an equity grant of 513 Restricted Stock Units on common stock as compensation. Each RSU represents one share of Kadant common stock and will vest in equal installments on the last day of each quarter of fiscal 2026, as long as she continues serving as a director.
Following the transactions reported, she directly holds 3,197 shares of Kadant common stock, in addition to the 513 RSUs awarded.
Kadant Inc Senior Vice President Michael C. Colwell reported multiple compensation-related stock transactions tied to restricted stock units (RSUs). On March 10, 2026, he exercised RSUs to acquire 1,632 shares of common stock at a conversion price of $0.00 per share.
To cover tax obligations, 743 shares of common stock were disposed of at $334.17 per share through issuer tax withholding, not open-market sales. After these vesting and tax-withholding entries, Colwell directly holds 3,945 shares of Kadant common stock. Footnotes state these are one-third vesting installments from performance- and time-based RSU awards granted in 2023, 2024, and 2025, each converting to common stock on a one-for-one basis.
Kadant Inc. senior vice president and general counsel Stacy D. Krause reported the vesting and settlement of several restricted stock unit (RSU) awards on March 10, 2026. She exercised RSUs into 2,172 shares of common stock at $0.00 per share. To cover tax obligations, 945 common shares were withheld at $334.17 per share through tax-withholding dispositions, which are not open-market sales. After these compensation-related transactions, Krause directly owned 2,590 shares of Kadant common stock.
Kadant Inc vice president Thomas Andrew Blanchard reported routine equity compensation activity. On March 10, 2026, he exercised and settled restricted stock units that had vested, converting 1,140 shares of RSUs into an equal number of Kadant common shares.
To cover tax obligations, 443 common shares were withheld at a price of $334.17 per share, with the remaining vested shares added to his holdings. Following these transactions, Blanchard directly owned 1,957 shares of Kadant common stock. Footnotes explain that these settlements reflect one-third vesting of performance- and time-based RSU awards granted between March 2023 and March 2025, each converting to common stock on a one-for-one basis at vesting.
Kadant Inc. Senior Vice President Peter J. Flynn reported routine equity compensation activity. On March 10, 2026, he exercised restricted stock units that delivered a total of 193 shares of common stock, tied to performance-based and time-based RSU awards granted on March 7, 2023.
To cover tax obligations, 76 shares were withheld at a price of $334.17 per share. After these transactions, Flynn directly held about 2,762.584 shares of Kadant common stock. No open-market purchases or sales were reported; the filing reflects standard vesting and tax withholding mechanics.
Kadant Inc. Executive Vice President & CFO Michael J. McKenney reported routine equity compensation activity. On March 10, 2026, a total of 3,488 restricted stock units from performance- and time-based awards granted in 2023, 2024, and 2025 vested and were converted into common stock on a one-for-one basis. To cover tax obligations, 1,690 common shares were withheld at a price of $334.17 per share under code F transactions, leaving no open-market sales. Following these transactions, McKenney directly holds 14,764 common shares of Kadant.
Kadant Inc Senior VP of Corporate Development Dara F. Mitchell reported the vesting and settlement of multiple restricted stock unit (RSU) awards on March 10, 2026. Performance-based and time-based RSUs granted in 2023, 2024, and 2025 vested one-third and were converted to common stock on a one-for-one basis.
Mitchell acquired a total of 1,425 shares of common stock through RSU conversions and delivered 692 shares at $334.17 per share to satisfy tax obligations. The net result is 733 additional shares of common stock, bringing Mitchell’s direct holdings to 1,949 shares.